Digoxin Use and Digoxin Toxicity in the Post-DIG Trial Era
- 30 June 2006
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 12 (5) , 343-346
- https://doi.org/10.1016/j.cardfail.2006.02.005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Impact of Clinical Trial Results on National Trends in α-Blocker Prescribing, 1996-2002JAMA, 2004
- Effects of Initiating Carvedilol in Patients With Severe Chronic Heart FailureJAMA, 2003
- Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart FailureNew England Journal of Medicine, 2002
- Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsThe Lancet, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- End of the Oldest Controversy in Medicine — Are We Ready to Conclude the Debate on Digitalis?New England Journal of Medicine, 1997
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based studyArchives of internal medicine (1960), 1996
- Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor TrialsJAMA, 1995